TIMP1 and cirrhosis of liver: Studies have confirmed that IFN-α gene therapy induces immunoregulation, anti-proliferation, and apoptosis-promoting activities, which can control tumor growth, reduce the expression of transforming growth factor-β (TGF-β) and tissue inhibitor of metalloproteinase-1 (TIMP-1), and improve liver cirrhosis [66].